144
edits
SQTS: Difference between revisions
Jump to navigation
Jump to search
m
no edit summary
mNo edit summary |
mNo edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 19: | Line 19: | ||
==Genetic diagnosis== | ==Genetic diagnosis== | ||
[[Image:ShortQT_syndrome_mechanism. | [[Image:ShortQT_syndrome_mechanism.svg|thumb|right]] | ||
In a quarter of the patients a mutation is found, predominantly in the KCNH2 gene (SQTS1). This gain-of-function mutation causes an increase in the potassium efflux and, subsequently, to a decrease of the myocyte refractory period. Mutations in the KCNQ1, KCNJ2 and possibly CACNxxx genes are also associated with the SQTS. | In a quarter of the patients a mutation is found, predominantly in the KCNH2 gene (SQTS1). This gain-of-function mutation causes an increase in the potassium efflux and, subsequently, to a decrease of the myocyte refractory period. Mutations in the KCNQ1, KCNJ2 and possibly CACNxxx genes are also associated with the SQTS. | ||